マイクロ流体市場：製品別（デバイス、コンポーネント（チップ、センサー、マイクロニードル、ポンプ、バルブ）、用途別（IVD（POC、臨床、獣医）、研究（プロテオミック、ゲノム、セルベース、キャピラリー）、製造）、エンドユーザー別（製薬、病院） - 2028年までの世界予測

Microfluidics Market by Product (Device, Component (Chip, Sensor, Microneedle, Pump, Valve), Application (IVD (POC, Clinical, Vet), Research (Proteomic, Genomic, Cell-based, Capillary), Manufacturing), End User (Pharma, Hospital) - Global Forecast to 2028

マイクロフルイディクス市場は、2023年に223億米ドルと推定され、予測期間中の年平均成長率は13.0%で、2028年には411億米ドルに達すると予測されている。マイクロ流体技術は、迅速な分析、試薬使用の削減、信頼性... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年9月11日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	357	361	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

マイクロフルイディクス市場は、2023年に223億米ドルと推定され、予測期間中の年平均成長率は13.0%で、2028年には411億米ドルに達すると予測されている。マイクロ流体技術は、迅速な分析、試薬使用の削減、信頼性の高い検査結果を提供することで、医薬品開発プロセス全体のコストを最小限に抑えます。これらすべての要因に加え、グルコースモニターや妊娠検査キットのようなポイントオブケア診断ツールの使用と受け入れが拡大した結果、マイクロ流体技術に対する需要が高まっている。

"マイクロ流体ベースのデバイスセグメントは、予測期間中、マイクロ流体市場で製品のタイプ別に最も高い成長を目撃すると予測されている。"
マイクロ流体市場は、製品によってマイクロ流体ベースのデバイスとマイクロ流体コンポーネントに大別される。製品別マイクロ流体市場は、2022年にはマイクロ流体ベースのデバイスセグメントが主流となる。このセグメントの成長率が最も高いのは、製薬・ライフサイエンス研究において技術的に洗練されたマイクロ流体ベースデバイスの利用が拡大していること、実験装置の小型化に対する要求が高まっていること、マイクロ流体ベースのPoCテストに対する消費者需要が増加していること、創薬へのマイクロ流体技術の応用が拡大していることなどが主な要因である。

"製品タイプ別では、マイクロ流体チップ分野が予測期間中に最も高い割合を占める"
流量・圧力センサー、流量・圧力コントローラー、マイクロポンプ、マイクロ流体バルブ、マイクロニードル、その他のマイクロ流体コンポーネントがタイプ別市場を構成するマイクロ流体コンポーネントの種類である。2022年のマイクロ流体コンポーネント市場は、マイクロ流体チップのカテゴリーが支配的であった。このマイクロ流体市場セグメントの成長は、PoC検査需要の高まり、個別化医療への嗜好の高まり、創薬・ライフサイエンス研究活動の増加、高速診断へのニーズの高まり、政府資金の増加などの要因によるものである。

「予測期間中、アジア太平洋市場が最も高い成長を遂げる
予測期間中、APACは最も速い速度で成長すると予測されている。この地域におけるマイクロ流体市場の成長を促進する主な要因は、高齢者数の増加、一人当たり所得の上昇、主要企業による医療産業への投資の増加、先端技術への需要の増加、アジア太平洋地域の様々な国々における農村部への民間病院の拡大などである。

本レポートで参照したマイクロ流体市場の主要参入企業（供給側）の内訳は以下の通りである：
a
- 企業タイプ別：ティア1：42%、ティア2：35%、ティア3：23
- 役職別Cレベル幹部：28%、取締役：35%、その他：2335%、その他37%
- 地域別北米：33%、ヨーロッパ：24%、アジア太平洋地域：18%、ラテンアメリカ：10%、中東：10%、アフリカ：5

マイクロ流体市場に参入している主な企業は、Parker Hannifin Corporation（米国）、SMC Corporation（日本）、Bio-Rad Laboratories, Inc.（米国）、Thermo Fisher Scientific Inc.（米国）、PerkinElmer, Inc.（米国）、Agilent Technologies, Inc.（米国）、Fluigent SA（フランス）、Aignep S.P.A. （イタリア）、Camozzi Automation Inc.(イタリア）、Camozzi Automation SPA Societá Unipersonale（イタリア）、Dolomite microfluidics（英国）、Elveflow（フランス）、Becton, Dickinson and Company（米国）、Illumina Inc.（米国）、F. Hoffmann-La Roche Ltd、IDEX Corporation（米国）、Danaher Corporation（米国）、Cellix Limited（アイルランド）、Fortive Corporation（米国）、（スイス）、Fluidigm Corporation（米国）、Abbott Laboratories（米国）。

調査対象範囲
この調査レポートは、さまざまなセグメントにわたるマイクロ流体市場を対象としています。製品別、用途別、エンドユーザー別、地域別など、さまざまなセグメントにわたる市場規模および市場の成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品および事業内容、最近の動向、主要市場戦略に関する主要な見解も掲載しています。

レポート購入の理由
本レポートは、マイクロ流体市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供することで、同市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より良い事業の位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
 主な促進要因（ポイントオブケア検査需要の高まり、技術進歩の高まり、データの精度と正確さへの注目の高まり、高い経済性、マイクロ流体チップの小型化による迅速な検査と携帯性の向上）、阻害要因（複雑で時間のかかる規制当局の承認プロセス、既存のワークフローへのマイクロ流体の組み込み）の分析、マイクロ流体市場の成長に影響を与える機会（マイクロ流体ベースの3D細胞培養システムの出現、主要成長市場であるアジア、マイクロ流体を用いた薬物送達技術の応用拡大、ライフサイエンスおよび製薬産業におけるマイクロ流体の応用拡大）および課題（マイクロ流体デバイスの標準化/商業化
- 市場への浸透：世界のマイクロ流体市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報を掲載しています。製品タイプ別、用途別、地域別に市場を分析しています。
- 製品の強化/革新：世界のマイクロ流体市場における今後の動向や製品発表に関する詳細な洞察。
- 市場開発：製品タイプ別、用途別、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化：世界のマイクロ流体市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力の評価：世界のマイクロ流体市場における主要企業の市場シェア、成長戦略、製品・サービス、能力を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 42
1.2.1 PRODUCT DEFINITIONS 42
1.2.2 INCLUSIONS & EXCLUSIONS 43
1.3 MARKET SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 YEARS CONSIDERED 45
1.4 CURRENCY 45
1.5 SCOPE-RELATED LIMITATIONS 46
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
1.7.1 ADDITION OF RECESSION IMPACT 47
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH DATA 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 50
FIGURE 2 PRIMARY SOURCES 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Key industry insights 53
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 54
2.2 MARKET SIZE ESTIMATION 54
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 55
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: DANAHER CORPORATION 55
FIGURE 7 REVENUE ANALYSIS OF TOP FOUR COMPANIES: MICROFLUIDICS-BASED DEVICES MARKET (2022) 56
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MICROFLUIDICS MARKET (2023–2028) 58
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59
FIGURE 10 TOP-DOWN APPROACH 59
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 61
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 61
2.4 MARKET SHARE ANALYSIS 62
2.5 STUDY ASSUMPTIONS 62
2.6 LIMITATIONS 63
2.7 RISK ASSESSMENT 63
TABLE 1 RISK ASSESSMENT: MICROFLUIDICS MARKET 63
2.8 RECESSION IMPACT ANALYSIS 63
3 EXECUTIVE SUMMARY 64
FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 64
FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 65
FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 65
FIGURE 15 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023 VS. 2028 (USD MILLION) 66
FIGURE 16 MICROFLUIDICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 66
FIGURE 17 GEOGRAPHIC SNAPSHOT: MICROFLUIDICS MARKET 67
4 PREMIUM INSIGHTS 68
4.1 MICROFLUIDICS MARKET OVERVIEW 68
FIGURE 18 RISING DEMAND FOR POCT TO DRIVE GLOBAL MICROFLUIDICS MARKET 68
4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION & COUNTRY 69
FIGURE 19 IVD HELD LARGEST SHARE OF APAC MICROFLUIDICS MARKET IN 2022 69
4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 70
4.4 REGIONAL MIX: MICROFLUIDICS MARKET (2021–2028) 71
FIGURE 21 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET THROUGHOUT FORECAST PERIOD 71
4.5 MICROFLUIDICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 71
FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES TILL 2028 71
5 MARKET OVERVIEW 72
5.1 MARKET DYNAMICS 72
FIGURE 23 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72
5.1.1 MARKET DRIVERS 73
5.1.1.1 Rising demand for point-of-care testing 73
FIGURE 24 GLOBAL CANCER INCIDENCE, 2020–2040 73
5.1.1.2 Rising technological advancements 74
TABLE 2 PRODUCT LAUNCHES BY MAJOR PLAYERS IN LAST THREE YEARS 74
5.1.1.3 Increasing focus on data precision and accuracy 74
5.1.1.4 Highly economical solution 75
5.1.1.5 Rapid testing and improved portability through microfluidic chip miniaturization 75
5.1.2 MARKET RESTRAINTS 76
5.1.2.1 Complex and time-consuming regulatory approval process 76
5.1.2.2 Incorporation of microfluidics into existing workflows 76
5.1.3 MARKET OPPORTUNITIES 77
5.1.3.1 Emergence of microfluidic-based 3D cell culture systems 77
5.1.3.2 Growth opportunities in Asia 77
5.1.3.3 Expanding applications of drug delivery technologies using microfluidics 78
5.1.3.4 Growing applications of microfluidics in life science & pharmaceutical industries 78
5.1.4 MARKET CHALLENGES 78
5.1.4.1 Standardization/commercialization of microfluidic devices 78
5.2 INDUSTRY TRENDS 79
5.2.1 SHIFTING TREND TOWARD E-HEALTH DIAGNOSTICS WITH INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES 79
5.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS 79
5.2.3 SHIFTING TREND TOWARDS ADOPTION OF POLYMERS 80
5.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC STARTUPS 80
TABLE 3 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET 80
5.3 VALUE CHAIN ANALYSIS 82
FIGURE 25 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 83
5.3.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 83
5.4 SUPPLY CHAIN ANALYSIS 84
FIGURE 26 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 85
5.5 ECOSYSTEM MARKET MAP 85
FIGURE 27 MICROFLUIDICS MARKET: ECOSYSTEM MARKET MAP 86
5.6 PORTER’S FIVE FORCES ANALYSIS 86
5.6.1 THREAT OF NEW ENTRANTS 87
5.6.2 THREAT OF SUBSTITUTES 87
5.6.3 BARGAINING POWER OF SUPPLIERS 87
5.6.4 BARGAINING POWER OF BUYERS 88
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.7 REGULATORY ANALYSIS 88
5.7.1 NORTH AMERICA 88
5.7.1.1 US 88
TABLE 4 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES 89
FIGURE 28 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 89
5.7.1.2 Canada 90
TABLE 5 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 90
FIGURE 29 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA 90
5.7.2 EUROPE 91
TABLE 6 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 91
FIGURE 30 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 92
5.7.3 ASIA PACIFIC 93
5.7.3.1 Japan 93
TABLE 7 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 93
5.7.3.2 China 94
TABLE 8 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 94
5.7.3.3 India 94
FIGURE 31 INDIA: REGULATORY PROCESS FOR IVD DEVICES 95
5.8 PATENT ANALYSIS 95
5.8.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 95
FIGURE 32 PATENT PUBLICATION TRENDS (2013–SEPTEMBER 2023) 96
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 96
FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2013–AUGUST 2023) 96
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR MICROFLUIDICS PATENTS (JANUARY 2013–SEPTEMBER 2023) 97
5.9 TECHNOLOGY ANALYSIS 97
5.9.1 KEY TECHNOLOGIES 97
5.9.1.1 Biorecognition elements 98
5.9.1.2 Material science 98
5.9.1.3 Microfabrication 99
5.9.1.4 Direct-write 99
5.9.2 COMPLEMENTARY TECHNOLOGIES 99
5.9.2.1 MEMS 100
5.9.2.1.1 Micropumps 100
5.9.2.1.2 Microneedles 100
5.9.2.1.3 Microsensors/Transducers 101
5.9.3 ADJACENT TECHNOLOGIES 101
5.9.3.1 3D printing 101
5.9.3.2 Lab-on-fiber 102
5.9.4 KEY CONFERENCES & EVENTS 102
TABLE 9 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023–2024) 102
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 103
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103
5.10.2 BUYING CRITERIA 104
FIGURE 36 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104
TABLE 11 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104
5.11 PRICING ANALYSIS 105
5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 105
5.11.2 AVERAGE SELLING PRICE TREND, BY COMPONENT 106
5.12 END-USER PERSPECTIVE & UNMET NEEDS 106
5.13 AI INTEGRATION IN MICROFLUIDICS MARKET 107
5.13.1 ARTIFICIAL INTELLIGENCE AND MICROFLUIDICS (PROJECT LOCAI) 107
5.13.2 AI AND MICROFLUIDICS TO BARCODE INDIVIDUAL CELLS 107
5.13.3 ARTIFICIAL INTELLIGENCE-CONTROLLED MICROFLUIDIC DEVICES FOR FLUID AUTOMATION AND BUBBLE REMOVAL OF IMMUNOASSAYS 108
6 MICROFLUIDICS MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
TABLE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
6.2 MICROFLUIDICS-BASED DEVICES 110
6.2.1 RISING ADOPTION ATTRIBUTED TO VARIOUS ADVANTAGES OF MICROFLUIDICS DEVICES 110
TABLE 13 MICROFLUIDICS-BASED DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
6.3 MICROFLUIDIC COMPONENTS 112
TABLE 14 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.3.1 BY TYPE 113
TABLE 15 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
6.3.1.1 Microfluidic chips 113
6.3.1.1.1 Chips to hold largest share of components market 113
TABLE 16 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS 114
TABLE 17 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.3.1.2 Flow & pressure sensors 116
6.3.1.2.1 Advantages in cytometry and POCT To drive adoption in labs and research institutes 116
TABLE 18 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS 116
TABLE 19 FLOW & PRESSURE SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
6.3.1.3 Flow & pressure controllers 118
6.3.1.3.1 High accuracy and control to boost growth 118
TABLE 20 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS 118
TABLE 21 FLOW & PRESSURE CONTROLLERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.3.1.4 Microfluidic valves 119
6.3.1.4.1 Importance of valves in microfluidics to ensure sustained demand 119
TABLE 22 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS 120
TABLE 23 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.3.1.5 Micropumps 123
6.3.1.5.1 Need for precise fluid control and device miniaturization to support demand 123
TABLE 24 MICROPUMPS OFFERED BY KEY PLAYERS 124
TABLE 25 MICROPUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.3.1.6 Microneedles 125
6.3.1.6.1 Convenience, painlessness, and widespread availability of injectable drugs to boost adoption 125
TABLE 26 MICRONEEDLES OFFERED BY KEY PLAYERS 126
TABLE 27 MICRONEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.3.1.7 Other components 127
TABLE 28 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
6.3.2 BY MATERIAL 128
TABLE 29 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 128
6.3.2.1 Silicon 128
6.3.2.1.1 Silicon to dominate materials market 128
TABLE 30 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
6.3.2.2 Polymers 129
6.3.2.2.1 Higher performance than glass or silicon to drive adoption 129
TABLE 31 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.3.2.3 Glass 130
6.3.2.3.1 Fragility of glass-based components to limit adoption 130
TABLE 32 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
7 MICROFLUIDICS MARKET, BY APPLICATION 132
7.1 INTRODUCTION 133
TABLE 33 MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133
7.2 IVD 133
TABLE 34 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 35 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
7.2.1 CLINICAL DIAGNOSTICS 135
7.2.1.1 Rising viral outbreaks to drive market 135
TABLE 36 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.2.2 POCT 136
7.2.2.1 POCT to hold second-largest share in IVD segment 136
TABLE 37 MICROFLUIDICS MARKET FOR POCT, BY COUNTRY, 2021–2028 (USD MILLION) 137
7.2.3 VETERINARY DIAGNOSTICS 138
7.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to support market growth 138
TABLE 38 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 138
7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING 139
TABLE 39 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 40 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140
7.3.1 LAB ANALYTICS 140
TABLE 41 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 42 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
7.3.1.1 Proteomic analysis 142
7.3.1.1.1 Increasing demand for rapid proteomic analysis in drug development to propel market 142
TABLE 43 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 143
7.3.1.2 Genomic analysis 143
7.3.1.2.1 Increasing focus on decoding genomes to boost adoption of microfluidics in genomics 143
TABLE 44 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.3.1.3 Cell-based assays 145
7.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development to support market growth 145
TABLE 45 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 145
7.3.1.4 Capillary electrophoresis 146
7.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive market 146
TABLE 46 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 147
7.3.2 MICRODISPENSING 147
7.3.2.1 Low sample & reagent consumption and ease of use to propel adoption of microdispensing systems 147
TABLE 47 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.3.3 MICROREACTIONS 148
7.3.3.1 Increasing need for optimizing research and production to boost usage of microreaction technology 148
TABLE 48 MICROFLUIDICS MARKET FOR MICROREACTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
7.4 THERAPEUTICS 150
TABLE 49 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 50 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 151
7.4.1 DRUG DELIVERY 151
7.4.1.1 Drug discovery to hold largest share 151
TABLE 51 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152
7.4.2 WEARABLE DEVICES 153
7.4.2.1 Increasing demand for microfluidics-integrated wearable devices to boost growth 153
TABLE 52 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 154
8 MICROFLUIDICS MARKET, BY END USER 155
8.1 INTRODUCTION 156
TABLE 53 MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 156
8.2 HOSPITALS & DIAGNOSTIC CENTERS 156
8.2.1 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE END-USER MARKET 156
TABLE 54 MICROFLUIDICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 157
8.3 ACADEMIC & RESEARCH INSTITUTES 158
8.3.1 GROWING USE OF MICROFLUIDICS IN R&D AND RISING FUNDING TO FAVOR MARKET 158
TABLE 55 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 159
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159
8.4.1 GROWING FOCUS ON LAUNCHING QUALITY DRUGS TO DRIVE MARKET 159
FIGURE 37 FDA APPROVALS FOR PERSONALIZED MEDICINE (2018–2022) 160
TABLE 56 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 161
9 MICROFLUIDICS MARKET, BY REGION 162
9.1 INTRODUCTION 163
FIGURE 38 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2022) 163
TABLE 57 MICROFLUIDICS MARKET, BY REGION, 2021–2028 (USD MILLION) 164
9.2 NORTH AMERICA 164
9.2.1 NORTH AMERICA: RECESSION IMPACT 165
FIGURE 39 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 165
TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 59 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 60 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 61 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 62 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 63 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 64 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 65 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 66 NORTH AMERICA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 168
TABLE 67 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 169
9.2.2 US 169
9.2.2.1 US to dominate North American microfluidics market 169
TABLE 68 US: KEY MACROINDICATORS 170
TABLE 69 US: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 170
TABLE 70 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 71 US: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 72 US: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 73 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 74 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 75 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 76 US: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 172
TABLE 77 US: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 173
9.2.3 CANADA 173
9.2.3.1 Strong infrastructure and availability of funding for biomedical research to support market growth 173
TABLE 78 CANADA: KEY MACROINDICATORS 174
TABLE 79 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 80 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 81 CANADA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 82 CANADA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 83 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 84 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 85 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 86 CANADA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 177
TABLE 87 CANADA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 177
9.3 EUROPE 178
9.3.1 EUROPE: RECESSION IMPACT 178
TABLE 88 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 89 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179
TABLE 90 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 91 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
TABLE 92 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 93 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 94 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 95 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 96 EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 182
TABLE 97 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 182
9.3.2 GERMANY 183
9.3.2.1 Germany to dominate European market 183
TABLE 98 GERMANY: KEY MACROINDICATORS 183
TABLE 99 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 100 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 101 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184
TABLE 102 GERMANY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 103 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 104 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 105 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 106 GERMANY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 186
TABLE 107 GERMANY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
9.3.3 FRANCE 187
9.3.3.1 Strong government support for genomics and proteomics research to drive market 187
TABLE 108 FRANCE: KEY MACROINDICATORS 187
TABLE 109 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 110 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 111 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 112 FRANCE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 113 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 114 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 115 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 116 FRANCE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 190
TABLE 117 FRANCE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 190
9.3.4 UK 191
9.3.4.1 Increasing incidence of infectious diseases to drive demand for POCT and microfluidics 191
TABLE 118 UK: KEY MACROINDICATORS 191
TABLE 119 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 191
TABLE 120 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 121 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 122 UK: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 123 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 124 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 125 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 126 UK: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 194
TABLE 127 UK: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 194
9.3.5 ITALY 195
9.3.5.1 Increasing demand for POCT to aid market growth 195
TABLE 128 ITALY: KEY MACROINDICATORS 195
TABLE 129 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 130 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 131 ITALY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196
TABLE 132 ITALY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 133 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 134 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 135 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 136 ITALY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 198
TABLE 137 ITALY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 198
9.3.6 SPAIN 199
9.3.6.1 Increasing incidence of infectious and chronic diseases to drive market 199
TABLE 138 SPAIN: KEY MACROINDICATORS 199
TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200
TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 141 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200
TABLE 142 SPAIN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 143 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 144 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 145 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 146 SPAIN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 202
TABLE 147 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 202
9.3.7 REST OF EUROPE 203
TABLE 148 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203
TABLE 149 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 150 REST OF EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 151 REST OF EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 152 REST OF EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 153 REST OF EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 154 REST OF EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 155 REST OF EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 206
TABLE 156 REST OF EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.4 ASIA PACIFIC 207
9.4.1 ASIA PACIFIC: RECESSION IMPACT 207
FIGURE 40 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 208
TABLE 157 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 209
TABLE 159 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 160 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 210
TABLE 161 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 162 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 163 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 164 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 165 ASIA PACIFIC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 212
TABLE 166 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 212
9.4.2 CHINA 213
9.4.2.1 China to hold major share of APAC microfluidics market 213
TABLE 167 CHINA: KEY MACROINDICATORS 213
TABLE 168 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 169 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 170 CHINA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214
TABLE 171 CHINA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 172 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 173 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 174 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 175 CHINA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 216
TABLE 176 CHINA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 216
9.4.3 JAPAN 217
9.4.3.1 Adoption of advanced lab instruments in research to drive market growth 217
TABLE 177 JAPAN: KEY MACROINDICATORS 217
TABLE 178 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 218
TABLE 179 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 180 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 218
TABLE 181 JAPAN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 182 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 183 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 184 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 185 JAPAN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 220
TABLE 186 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 220
9.4.4 INDIA 221
9.4.4.1 Growing pharma R&D and government funding for biotech to boost market growth 221
TABLE 187 INDIA: KEY MACROINDICATORS 221
TABLE 188 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 222
TABLE 189 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 190 INDIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222
TABLE 191 INDIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 192 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 193 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 194 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 195 INDIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 224
TABLE 196 INDIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 224
9.4.5 AUSTRALIA 225
9.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market 225
TABLE 197 AUSTRALIA: KEY MACROINDICATORS 225
TABLE 198 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225
TABLE 199 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 200 AUSTRALIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 226
TABLE 201 AUSTRALIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 202 AUSTRALIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 203 AUSTRALIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 204 AUSTRALIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 205 AUSTRALIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 228
TABLE 206 AUSTRALIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 228
9.4.6 SOUTH KOREA 229
9.4.6.1 Increasing healthcare expenditure to support growth 229
TABLE 207 SOUTH KOREA: KEY MACROINDICATORS 229
TABLE 208 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 229
TABLE 209 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 210 SOUTH KOREA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 211 SOUTH KOREA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 212 SOUTH KOREA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 213 SOUTH KOREA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 214 SOUTH KOREA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 215 SOUTH KOREA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 232
TABLE 216 SOUTH KOREA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 232
9.4.7 REST OF ASIA PACIFIC 233
TABLE 217 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 233
TABLE 218 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 219 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 220 ROAPAC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 221 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 222 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 223 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 224 ROAPAC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 235
TABLE 225 ROAPAC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 236

ページTOPに戻る

Table of Contents

Summary

The microfluidics market is valued at an estimated USD 22.3 billion in 2023 and is projected to reach USD 41.1 billion by 2028, at a CAGR of 13.0% during the forecast period. Microfluidics technologies minimize the overall cost of the drug development process by providing quick analysis, reduced reagent use, and reliable results of tests. Besides all of these factors, the demand for microfluidics technology is rising as a result of the expanding use and acceptance of point-of-care diagnostics tools like glucose monitors and pregnancy test kits.

“The microfluidic-based devices segment is projected to witness the highest growth in the microfluidics market, by type of products, during the forecast period.”
The microfluidics market can be broadly classified into microfluidic-based devices and microfluidic components, depending on the product. The microfluidics market by product was dominated by the microfluidic-based devices segment in 2022. This segment's highest growth rate can be largely attributed to the growing use of technologically sophisticated microfluidic-based devices in pharmaceutical and life science research, the increasing requirement for laboratory equipment miniaturization, increasing consumer demand for microfluidic-based PoC testing, and the growing application of microfluidic technology for drug discovery.

“The microfluidic chips segment, by product type, has the highest rate during the forecast period.”
The flow and pressure sensors, flow and pressure controllers, micropumps, microfluidic valves, microneedles, and other microfluidic components are the types of microfluidic components that make up the market by type. In 2022, the market for microfluidic components was dominated by the microfluidic chips category. The growth of this microfluidic market segment is attributed to factors such as rising demand for PoC testing, rising preference for personalized medicine, rising number of drug discovery and life science research activities, rising need for high-speed diagnostics, and rising government funding.

“Asia Pacific market to witness the highest growth during the forecast period.”
During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors promoting the growth of the microfluidics market in this region are the growing number of elderly people, rising per capita income, growing investments in the healthcare industry by key players, increasing demands for advanced technologies, and expansion of private sector hospitals to rural areas in various countries in the Asia Pacific.

A breakdown of the primary participants (supply-side) for the microfluidics market referred to for this report is provided below:
a
• By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
• By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
• By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%

The prominent players operating in the microfluidics market are Parker Hannifin Corporation (US), SMC Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Fluigent SA (France), Aignep S.P.A. (Italy), Camozzi Automation SPA Societá Unipersonale (Italy), Dolomite microfluidics (UK), Elveflow (France), Becton, Dickinson and Company (US), Illumina Inc. (US), F. Hoffmann-La Roche Ltd, IDEX Corporation (US), Danaher Corporation (US), Cellix Limited (Ireland), Fortive Corporation (US), (Switzerland), Fluidigm Corporation (US) and Abbott Laboratories (US).

Research Coverage:
The market study covers the microfluidics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, application, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall microfluidics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
 Analysis of key drivers (Rising demand for point-of-care testing, Rising technological advancements, Increasing focus on data precision and accuracy, Highly economical, Rapid testing and improved portability through microfluidic chip miniaturization), restraints (Complex and time-consuming regulatory approval process, Incorporation of the microfluidics into existing workflows), opportunities (Emergence of microfluidic-based 3D cell culture systems, Asia—a key growth market, Expanding applications of drug delivery technologies using microfluidics, Growing applications of microfluidics in the life sciences and pharmaceutical industries) and challenges (Standardization/commercialization of microfluidic devices) influencing the growth of the microfluidics market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global microfluidics market. The report analyzes this market by type of product , application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global microfluidics market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product , application, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global microfluidics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global microfluidics market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（chip）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（chip）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?